| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-10 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |